Trump, broader growth in focus as US companies prepare Q4 reports
Investors are watching to see if technology companies and related heavyweights will add to recent strong profit gains and ...
Globus Medical upgraded to neutral by BoA on Q4 performance
BofA Securities has upgraded Globus Medical (NYSE:GMED) to neutral from underperform, citing the company's strong Q4 revenue ...
Cruise Industry News36m
Royal Caribbean Sets Date for Q4 Earnings Call
A.M. Eastern Time on Tuesday, Jan. 28, 2025, to discuss the company's fourth quarter and full-year 2024 financial results.
manilatimes57m
Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis ("UC”) reaches 1,003 of 1,224 ...